A concise review of major challenges in the vaccination, diagnosis and treatment of novel coronavirus disease ۲۰۱۹
محل انتشار: مجله آرشیو رازی، دوره: 79، شماره: 6
سال انتشار: 1403
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 190
فایل این مقاله در 10 صفحه با فرمت PDF قابل دریافت می باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_ARCHRAZI-79-6_004
تاریخ نمایه سازی: 17 دی 1403
چکیده مقاله:
The rapid spread of severe acute respiratory syndrome coronavirus ۲ (SARS-CoV-۲) led to ۲۰۱۹ coronavirus (COVID-۱۹) pandemic worldwide. An efficient strategy to control the COVID-۱۹ pandemic includes the rapid recognition of patients and vaccination using accurate and reliable methods. Various diagnostic methods such as CT scan, serology and molecular methods have been applied for the COVID-۱۹ diagnosis. Moreover, various vaccines and antiviral drugs or immunotherapies have been utilized to combat the virus. This is particularly important for COVID-۱۹ patients at high risk of serious consequences. Various challenges in the prognosis, diagnosis, vaccination and treatment of COVID-۱۹ include variability in disease severity, emerging variants, individual factors and immune responses, co-infections and complications, limited long-term data, psychological and social factors, availability and accessibility, tests sensitivity and specificity, variability in symptoms, mild or asymptomatic cases, limited specific antiviral options, clinical heterogeneity, lack of universal treatment protocol, overwhelmed healthcare systems, management of severe cases, long-term effects and post-COVID syndrome, vaccine hesitancy, global cooperation and vaccine production capacity. This article describes the latest challenges and achievements in the prognosis, diagnosis, vaccination and therapy of COVID-۱۹. The consult with reliable sources such as national health authorities and the World Health Organization (WHO) is crucial to obtain the latest information on COVID-۱۹ vaccination, including eligibility, availability, and recommended protocols in any specific region. The treatment options and strategies continue to evolve. Healthcare professionals and researchers are working diligently to address therapy challenges and improve outcomes for individuals affected by COVID-۱۹. Randomized clinical studies designed to identify the most appropriate and proven treatment are essential both to reduce the prevalence of COVID-۱۹ and to prevent the prevalence of any pandemic in the future.
کلیدواژه ها:
نویسندگان
Nasrin Bargahi
Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran;
Abdolmajid Ghasemian
Noncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran
Reyhaneh Hoseinpoor
Department of Biotechnology, School of Advance Technologies in Medicine Shahid Beheshti University, Tehran, Iran
Shirin Mahmoodi
Department of Medical Biotechnology, School of Medicine, Fasa University of Medical Sciences, Fasa, Iran
مراجع و منابع این مقاله:
لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :